SB 38

  • Indiana Senate Bill
  • 2023 Regular Session
  • Introduced in Senate
  • Passed Senate Feb 06, 2023
  • House
  • Governor

Donation of income tax refund for cancer research.

Abstract

Establishes the Senator David C. Ford cancer research account (Ford account) within the Indiana health care account. Provides that a taxpayer may designate all or a part of the taxpayer's state income tax refund to be paid over to the Ford account. Provides that the budget agency shall distribute the money in the Ford account in equal amounts to the Indiana University Melvin and Bren Simon Cancer Center and the Purdue University Center for Cancer Research.

Bill Sponsors (10)

Votes


Actions


Mar 09, 2023

House

Representative Andrade M added as cosponsor

Feb 28, 2023

House

First reading: referred to Committee on Ways and Means

  • Reading-1
  • Referral-Committee
ways and means

Feb 09, 2023

Senate

Referred to the House

Feb 07, 2023

Senate

Senator Qaddoura added as third author

Feb 06, 2023

Senate

Third reading: passed; Roll Call 62: yeas 49, nays 0

Senate

House sponsor: Representative Clere

Senate

Cosponsors: Representatives Heaton and Pfaff

Senate

Senator Pol added as coauthor

Feb 02, 2023

Senate

Senator Charbonneau added as second author

Senate

Second reading: ordered engrossed

Senate

Senator Walker G added as coauthor

Senate

Senator Randolph added as coauthor

Jan 31, 2023

Senate

Committee report: do pass, adopted

Jan 09, 2023

Senate

First reading: referred to Committee on Tax and Fiscal Policy

  • Reading-1
  • Referral-Committee
tax and fiscal policy

Senate

Authored by Senator Ford Jon

Bill Text

Bill Text Versions Format
Introduced Senate Bill (S) PDF
Senate Bill (S) PDF

Related Documents

Document Format
Fiscal Note: SB0038.02.COMS.FN001 PDF
Fiscal Note: SB0038.02.COMS.FN002 PDF
Fiscal Note: SB0038.02.COMS.FN003 PDF

Sources

Data on Open States is updated periodically throughout the day from the official website of the Indiana General Assembly.

If you notice any inconsistencies with these official sources, feel free to file an issue.